ZA200309739B - Gene associated with leishmania parasite. - Google Patents

Gene associated with leishmania parasite.

Info

Publication number
ZA200309739B
ZA200309739B ZA200309739A ZA200309739A ZA200309739B ZA 200309739 B ZA200309739 B ZA 200309739B ZA 200309739 A ZA200309739 A ZA 200309739A ZA 200309739 A ZA200309739 A ZA 200309739A ZA 200309739 B ZA200309739 B ZA 200309739B
Authority
ZA
South Africa
Prior art keywords
gene associated
leishmania parasite
leishmania
parasite
gene
Prior art date
Application number
ZA200309739A
Other languages
English (en)
Inventor
Yosser Ben Achour
Mehdi Chenik
Koussay Dellagi
Hechmi Louzir
Original Assignee
Pasteur Institut
Pasteur Institut Tunis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut, Pasteur Institut Tunis filed Critical Pasteur Institut
Publication of ZA200309739B publication Critical patent/ZA200309739B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90—Isomerases (5.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
ZA200309739A 2001-06-18 2003-12-17 Gene associated with leishmania parasite. ZA200309739B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0107985A FR2826018B1 (fr) 2001-06-18 2001-06-18 Gene associe a la virulence du parasite leishmania

Publications (1)

Publication Number Publication Date
ZA200309739B true ZA200309739B (en) 2004-10-12

Family

ID=8864458

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200309739A ZA200309739B (en) 2001-06-18 2003-12-17 Gene associated with leishmania parasite.

Country Status (16)

Country Link
EP (1) EP1414967B1 (cs)
JP (2) JP2004537299A (cs)
KR (1) KR20040023621A (cs)
CN (2) CN1526017A (cs)
AU (2) AU2002345672B2 (cs)
BR (1) BR0210486A (cs)
CZ (1) CZ20033430A3 (cs)
FR (1) FR2826018B1 (cs)
HR (1) HRP20031046A2 (cs)
HU (1) HUP0400204A3 (cs)
MX (1) MXPA03011904A (cs)
NZ (1) NZ530459A (cs)
PL (1) PL367113A1 (cs)
WO (1) WO2002103002A2 (cs)
YU (1) YU99603A (cs)
ZA (1) ZA200309739B (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2540736A1 (en) * 2005-04-08 2006-10-08 Institut Pasteur Polypeptides of leishmania major and polynucleotides encoding same and vaccinal, therapeutical and diagnostic applications thereof
US20070015803A1 (en) * 2005-04-12 2007-01-18 Romark Laboratories L.C. Methods for treating diseases through interruption of protein maturation, compounds that inhibit the function of molecular chaperones such as protein disulfide isomerases or interfere with glycosylation, pharmaceutical compositions comprising them, and screening methods for identifying therapeutic agents
EP2141248B1 (en) * 2008-07-03 2012-12-12 Institut Pasteur Methods to identify leishmania virulence factors
SA110310855B1 (ar) * 2009-11-13 2014-09-16 Laboratories Leti S L Unipersonal استخدام مصدر l3 و/ أو l5 كلقاح أو كوسيلة تشخيصية لمرض طفيلي
AR083829A1 (es) * 2010-11-10 2013-03-27 Leti S L Unipersonal Lab Coadyuvante con potencialidad inmunogenica incrementada
CN106085995B (zh) * 2016-06-15 2019-07-12 华南理工大学 一种基因定点改造的蛋白质二硫键异构酶及其应用
WO2018175346A1 (en) * 2017-03-20 2018-09-27 Spectral Platforms, Inc. Spectroscopic methods to detect and characterize microorganisms

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2105538C (en) * 1993-09-03 1999-03-09 Gregory Matlashewski Differentially expressed leishmania genes and proteins

Also Published As

Publication number Publication date
MXPA03011904A (es) 2005-07-01
FR2826018B1 (fr) 2005-01-07
PL367113A1 (en) 2005-02-21
HRP20031046A2 (en) 2004-04-30
NZ530459A (en) 2008-04-30
FR2826018A1 (fr) 2002-12-20
CZ20033430A3 (cs) 2004-05-12
CN101274960A (zh) 2008-10-01
CN1526017A (zh) 2004-09-01
JP2009254386A (ja) 2009-11-05
BR0210486A (pt) 2004-08-17
KR20040023621A (ko) 2004-03-18
HUP0400204A3 (en) 2010-01-28
JP2004537299A (ja) 2004-12-16
EP1414967A2 (fr) 2004-05-06
AU2008203830A1 (en) 2008-09-11
AU2002345672B2 (en) 2008-05-29
YU99603A (sh) 2006-05-25
EP1414967B1 (fr) 2015-04-15
WO2002103002A2 (fr) 2002-12-27
WO2002103002A3 (fr) 2004-02-26
HUP0400204A2 (hu) 2005-04-28

Similar Documents

Publication Publication Date Title
GB2380760B (en) Retaining member
MXPA03005081A (es) Elevador.
MXPA01009037A (es) I-bet.
GB2378232B (en) Polygon connection assembly
MXPA03007130A (es) Conjugados de peg de hgf-nk4.
MXPA03009089A (es) Bifenilcarboxamidas reductoras de lipidos.
ZA200309739B (en) Gene associated with leishmania parasite.
AU2002345672A1 (en) Gene associated with leishmania parasite virulence
IL158124A0 (en) Leishmania vaccines
GB0122232D0 (en) Gene expression
HK1059781A1 (en) New phenylpiperazines.
EP1428891A4 (en) NEW GENE NEDL-1
GB0104247D0 (en) Assembly
GB0111886D0 (en) Genetic typing
ZA200207552B (en) Connector.
GB2383044B (en) Alstroem syndrome gene
AU2002312624A8 (en) Drug metabolizing enzymes
GB0107065D0 (en) Assembly
GB0130194D0 (en) Jetlift with downward thrust
GB0128769D0 (en) Gene
GB0122730D0 (en) Gene Linkakge
GB0116360D0 (en) Gene PRPC8
GB0109155D0 (en) Gene sequence
ZA200208240B (en) Cracker.
GB0109461D0 (en) New Gene